Navigation Links
Medical Device Veteran and Author, Rudy Mazzocchi is Honored as One of Top 50 Innovators at the 2013 Venture Summit Conference
Date:2/5/2013

cal Trials within the next 12 months to obtain CE Mark Approval by the end of 2014.

About ELENZA:

ELENZA, Inc. is a venture-funding company developing the world's first electronic "AutoFocal" Intraocular Lens to compete in the multi-billion dollar IOL market. Elenza's highly proprietary next generation Accommodating IOL is designed to give patients a complete visual range, providing effective near, intermediate and distance vision. These electro-active IOLs use a proprietary combination of liquid-crystal chemistry, electricity, and integrated-circuitry to create smart optics, which will provide patients with the ability to see more naturally and clearly over the full range of vision. The technology includes an electro-active switchable element that automatically adjusts focusing power electronically, in milliseconds, to maintain constant in-focus vision for various working needs and/or light environments. The lens is controlled by a micro-sized power-cell with an expected 50+ year rechargeable cycle life.

About Mazzocchi:

Rudy is best known as a medical device and biotechnology entrepreneur, inventor, and angel investor, with a history of starting new technology ventures throughout the U.S. and Europe. He’s been privileged to have the opportunity to see the newest innovations in healthcare and work with some of the most brilliant researchers, scientists and physicians in the industry.

Authoring more than 50 patents, he has helped pioneer new companies involved in cardiology, oncology, orthopedics, neurosurgery, ophthalmology and even embryonic stem-cell development. Through these efforts, he has become the recipient of many technology and business awards, including the Ernst & Young Entrepreneur of the Year Award in
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Chief Medical Officers in Biotechs Finally Have Their Own Conference
2. Versalis and Yulex partner to produce guayule-based biorubber for consumer, medical and industrial applications
3. Hadasit Bio-Holdings Ltd. Portfolio Companies - ProtAb Ltd. and KAHR Medical Ltd. to Receive NIS 10.7 Million (Over $2.8 Million USD) in Additional Government Grants
4. Touch Medical Media Splits From Touch Briefings, Launches a Series of Cutting Edge, Free to Access, Educational Resources and Signs an Updated Media Partnership With ECCO, The European CanCer Organisation Representing 60,000 Oncology Professionals
5. U.S. Implantable Medical Devices Market is Expected to Reach USD 73.9 Billion by 2018: Transparency Market Research
6. Market Outlook: The Future of Biomedical Materials
7. New EMR Comparison Website Launches Crowdsourcing Electronic Medical Record Software Reviews and Comparisons
8. California Biomedical Companies Report Higher Product Approvals, Fewer Delays
9. Fujimoto Honored with Britton Chance Biomedical Optics Award
10. Market for Biologic Imaging Reagents and Medical Imaging & Diagnosing Analyzed in New Research Reports at ReportsnReports.com
11. Doctors Without Borders and DNDi: Millions of Patients Still Waiting for Medical “Breakthroughs” Against Neglected Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... CA (PRWEB) June 18, 2013 (PRWEB) June 18, ... #1 time and attendance system in North America, ... that shares employee data and payroll records between ... AccountLinx Plus automates ExakTime software setup and ... software imports employee data from a business’ current ...
(Date:6/18/2013)... Miami, FL (PRWEB) June 18, 2013 The ... associate the skin as an important human body part. Similar ... cared for in order to function, repair and grow. Recent ... with vitamins and supplements, is just as important as other ... and supplements to aid in skin cell reproduction, increase the ...
(Date:6/18/2013)... RegeneCure announced today the start of ... Regeneration (GBR) Dental Membrane as a bone stimulating aid for ... when patients have a tooth replaced with a dental implant ... implant. Consequently there is often a need to support the ... The bone substitute material, in turn, needs to be held ...
(Date:6/18/2013)... 2013 Edison Investment ... announces the initiation of full coverage of ... developing and marketing products for orphan oncology ...      (Logo: http://photos.prnewswire.com/prnh/20130417/608168) Edison has ... investment merits of BioAlliance Pharma, focusing in ...
Breaking Biology Technology:ExakTime Introduces AccountLinx Plus 2Natural Acne Remedies Through Diet, Probiotic Action Shares New Insight on What Foods May Help Lead to Clear Skin 2RegeneCure Starts Clinical Study Using Polymeric Bone Stimulating Membrane for Dental Implants 2RegeneCure Starts Clinical Study Using Polymeric Bone Stimulating Membrane for Dental Implants 3Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 2Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 3
... March 18 Ingenuity Systems, the,leading provider ... has,announced that they have extended and expanded ... to Ingenuity Pathways Analysis,(IPA) software. The new ... to researchers for rapid assessment of the ...
... engineer genetic modifications, thereby providing scientists with a ... food production to drug discovery. However, this sophisticated ... threat of engineered pathogens. New research published in ... that computational tools could become a vital resource ...
... New Monograph Strengthens Safety Nets to Prevent Serious Health ... ... 17 The U.S. Pharmacopeial (USP),Convention today announced a ... official compendium of the United States. The,revision strengthens safety ...
Cached Biology Technology:Ingenuity Systems Extends Enterprise-Level Software Agreement With GlaxoSmithKline 2On the trail of rogue genetically modified pathogens 2USP Announces Revised Glycerin Monograph 2USP Announces Revised Glycerin Monograph 3
(Date:6/19/2013)... for human consumption qualifies as a gluten-free cereal that ... scientists have confirmed in a study published in ACS, ... , Joyce Irene Boye and colleagues point out that ... alone have CD. They develop gastrointestinal and other symptoms ... contain gluten-related proteins. Boye,s team sought to expand dietary ...
(Date:6/19/2013)... fall 2012, the European Medicines Agency (EMA) approved ... first ever gene therapy for clinical use in ... had developed AAV-LPL S447X for the treatment of ... deficiency (LPLD) which affects approximately one or two ... severe, life-threatening inflammations of the pancreas. Afflicted individuals ...
(Date:6/18/2013)... A UT Arlington environmental engineer has been awarded ... District to ensure water quality and flow in ... Project. , Andrew Kruzic, UT Arlington associate professor ... and locations to add monochloramine to the water ... the new pump stations and pipelines. Adding monochloramine ...
Breaking Biology News(10 mins):No danger of cancer through gene therapy virus 2UT Arlington research to benefit quality, flow in 150-mile Integrated Pipeline 2
... -- The number of overweight and obese Americans continues to ... up to 20 percent are obese. While the number of ... increase of overweight infants -- individuals under 11 months old ... pregnant women who are overweight/obese are more likely to give ...
... Elsevier announced today that it is launching a ... Engineering. The journal will be published bimonthly, and will ... of natural gas science and engineering. The first issue ... Natural Gas Science and Engineering will cover the fields ...
... Ohio State University have found that the number of copies ... cancer in a mouse model. Publishing in the Jan. 3 ... or Down syndrome in humans, can repress tumor growth. ... whether people with Down syndrome develop cancer less often than ...
Cached Biology News:Mom's obesity during conception phase may set the stage for offspring's obesity risk 2Mom's obesity during conception phase may set the stage for offspring's obesity risk 3Mom's obesity during conception phase may set the stage for offspring's obesity risk 4Elsevier launches new journal: Journal of Natural Gas Science and Engineering 2Gene dose affects tumor growth 2
Immunogen: Purified native p24 from strain IIIB. Storage: -20 C, Avoid Freeze/Thaw Cycles...
EDG-1CT (endothelial cell differentiation gene-1, C terminal)...
Request Info...
... epitope is specific for Kir2.1 and ... known protein.,SPECIES REACTIVITIES: The immunogen ... porcine and guinea pig. It is ... (17/19 residues) and chick (15/19 residues). ...
Biology Products: